PHARMACOLOGICALLY ACCEPTABLE SALT OF 1,3,4OXADIAZOLE COMPOUND OR HYDRATE THEREOF

摘要

A pharmacologically acceptable salt of a compound (1), which has an FXa inhibitory effect and is useful as a pharmaceutical compound for prevention/treatment of thrombotic and/or embolic diseases, a hydrate thereof, a crystal of the salt or hydrate, and methods for commercially producing the same. Specifically disclosed is a pharmacologically acceptable salt of N1-(5-chloropyridin-2-yl)-N2-[(1S,2R,4S)-2-{[(5-methyl- 4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino}-4-([1,3,4]oxadiazol-2-yl)cyclohexyl]ethanediamide, a hydrate thereof, or a crystal of the salt or hydrate.